Amended Loan Schedule to Secured Promissory Note between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC (November 10, 2022)
This document is an amended loan schedule attached to a secured promissory note between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC. It lists the original loan amount and subsequent additional loans made between November 2022 and May 2023, increasing the total principal from $2,319,279 to $3,469,279. The schedule details the dates and amounts of each loan, updating the aggregate principal owed under the original secured promissory note.
Exhibit 10.70
Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc and Abuse Deterrent Pharma, LLC
| Date |
| Principal |
| Aggregated |
| |||
| | | | | | ||||
Original Secured Promissory Note | | 11/10/2022 | | $ | 2,319,279 | | $ | 2,319,279 | |
Additional loans to be included: | | | | | | | |||
Loan #1 | | 12/22/2022 | | $ | 250,000 | | $ | 2,569,279 | |
Loan #2 | | 1/19/2023 | | $ | 250,000 | | $ | 2,819,279 | |
Loan #3 | | 2/22/2023 | | $ | 250,000 | | $ | 3,069,279 | |
Loan #4 | | 3/20/2023 | | $ | 250,000 | | $ | 3,319,279 | |
Loan #5 | | 5/19/2023 | | $ | 150,000 | | $ | 3,469,279 | |
